Pharmacokinetics of xamoterol glucuronidation in the ratin vivoand in liver perfusion
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 17 (1) , 85-92
- https://doi.org/10.3109/00498258709047178
Abstract
1. Xamoterol has a phenolic hydroxyl group at which both sulphation and glucuronidation may occur. In the rat in vim it is almost exclusively glucuronidated. In bile the glucuronide conjugate is the only metabolite of xamoterol. In urine equal amounts of the glucuronide conjugate and unchanged xamoterol are present, together with a small amount of the sulphate conjugate (approx. 1% of the dose). 2. The t1/2 of excretion of the glucuronide in bile was the same as the t1/2 for excretion of unchanged xamoterol in urine. The t1/2 for urinary excretion of the glucuronide conjugate was longer than that for its biliary excretion. 3. In the isolated perfused rat liver glucuronidation was also the almost exclusive metabolic pathway. The extraction ratio of xamoterol by the liver was approx. 0.15. 4. Since xamoterol is a very water-soluble compound, and is almost exclusively glucuronidated in the rat, it is an excellent model substrate for investigations on the pharmacokinetics of glucuronidation in the rat in vivo and in isolated perfused organs.This publication has 3 references indexed in Scilit:
- The in vitro pharmacology of xamoterol (ICI 118,587)British Journal of Pharmacology, 1985
- THE METABOLISM OF ICI 118,587, A PARTIAL AGONIST OF BETA-1-ADRENOCEPTORS, IN MICE, RATS, RABBITS, DOGS, AND HUMANS1984
- THE CARDIOVASCULAR EFFECTS OF ICI 118,587: A β1‐ADRENOCEPTOR PARTIAL AGONISTBritish Journal of Pharmacology, 1982